Fidelity Investments
HZNP

Fidelity Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Fidelity Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-205,419
Closed -$23.8M – 5778
2023
Q3 		$23.8M Buy
205,419
+10,899
+6% +$1.17M ﹤0.01% 1524
2023
Q2 		$20M Buy
194,520
+19,497
+11% +$2.06M ﹤0.01% 1635
2023
Q1 		$19.1M Buy
175,023
+18,117
+12% +$2M ﹤0.01% 1625
2022
Q4 		$17.9M Sell
156,906
-1,571,648
-91% -$131M ﹤0.01% 1659
2022
Q3 		$107M Sell
1,728,554
-10,385,065
-86% -$726M 0.01% 930
2022
Q2 		$966M Sell
12,113,619
-3,033,924
-20% -$287M 0.1% 187
2022
Q1 		$1.59B Sell
15,147,543
-723,499
-5% -$70.5M 0.13% 140
2021
Q4 		$1.71B Buy
15,871,042
+266,560
+2% +$29.1M 0.13% 133
2021
Q3 		$1.71B Buy
15,604,482
+789,431
+5% +$82M 0.14% 122
2021
Q2 		$1.39B Buy
14,815,051
+875,057
+6% +$80.5M 0.11% 161
2021
Q1 		$1.28B Buy
13,939,994
+686,552
+5% +$57.9M 0.11% 172
2020
Q4 		$969M Sell
13,253,442
-3,127,275
-19% -$232M 0.09% 215
2020
Q3 		$1.27B Buy
16,380,717
+9,092,249
+125% +$626M 0.13% 137
2020
Q2 		$405M Buy
7,288,468
+1,317,555
+22% +$56.4M 0.04% 377
2020
Q1 		$177M Sell
5,970,913
-571,448
-9% -$19.3M 0.02% 546
2019
Q4 		$237M Buy
6,542,361
+275,343
+4% +$8.44M 0.03% 589
2019
Q3 		$171M Buy
6,267,018
+1,170,022
+23% +$30.3M 0.02% 679
2019
Q2 		$123M Sell
5,096,996
-108,221
-2% -$2.75M 0.01% 832
2019
Q1 		$138M Buy
5,205,217
+3,242,071
+165% +$76.8M 0.02% 781
2018
Q4 		$38.4M Buy
1,963,146
+1,538,056
+362% +$30.1M 0.01% 1258
2018
Q3 		$8.32M Sell
425,090
-59,206
-12% -$1.13M ﹤0.01% 1985
2018
Q2 		$8.02M Hold
484,296
– – ﹤0.01% 2009
2018
Q1 		$6.88M Sell
484,296
-190,600
-28% -$2.82M ﹤0.01% 2068
2017
Q4 		$9.85M Sell
674,896
-101,600
-13% -$1.43M ﹤0.01% 1962
2017
Q3 		$9.85M Sell
776,496
-488,700
-39% -$6.21M ﹤0.01% 1944
2017
Q2 		$15M Sell
1,265,196
-1,187,500
-48% -$14.8M ﹤0.01% 1792
2017
Q1 		$36.3M Sell
2,452,696
-3,250,263
-57% -$52.6M ﹤0.01% 1460
2016
Q4 		$92.3M Sell
5,702,959
-7,077,135
-55% -$128M 0.01% 1027
2016
Q3 		$232M Sell
12,780,094
-10,573,322
-45% -$207M 0.03% 605
2016
Q2 		$385M Buy
23,353,416
+401,302
+2% +$6.49M 0.05% 393
2016
Q1 		$380M Sell
22,952,114
-503,400
-2% -$8.81M 0.05% 374
2015
Q4 		$508M Buy
23,455,514
+130,372
+0.6% +$2.54M 0.07% 301
2015
Q3 		$462M Buy
23,325,142
+779,052
+3% +$24.6M 0.07% 325
2015
Q2 		$783M Buy
22,546,090
+13,836,242
+159% +$422M 0.1% 220
2015
Q1 		$226M Buy
8,709,848
+2,638,452
+43% +$48.4M 0.03% 632
2014
Q4 		$78.3M Sell
6,071,396
-133,372
-2% -$1.67M 0.01% 1131
2014
Q3 		$76.2M Buy
6,204,768
+1,779,700
+40% +$20.7M 0.01% 1100
2014
Q2 		$70M Sell
4,425,068
-6,032
-0.1% -$86.1K 0.01% 1196
2014
Q1 		$67M Buy
4,431,100
+515,700
+13% +$5.82M 0.01% 1185
2013
Q4 		$29.8M Sell
3,915,400
-2,221,627
-36% -$12M ﹤0.01% 1552
2013
Q3 		$20.7M Hold
6,137,027
– – ﹤0.01% 1672
2013
Q2 		$15.1M Buy
+6,137,027
New +$14.7M ﹤0.01% 1773

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fidelity Investments's HZNP Position: Q4 2023 in Review

Fidelity Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 205,419 shares — an estimated $23.8M sold.

Fidelity Investments first reported a position in HZNP in Q2 2013 and held it in 42 quarters. The position peaked at $1.71B in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Fidelity Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Fidelity Investments sold 205,419 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $23.8M.
  • Fidelity Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 42 quarters.
  • Fidelity Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.71B in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.